Westborough, MA, United States of America

Ole Petter Veiby

This inventor holds 8 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignees: Millennium Pharmaceuticals Limited, The University of Texas System, Ut Board of Regents. Active years: 2009-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ole Petter Veiby. Retrieved from https://idiyas.com/inventor/ole-petter-veiby

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 5)

% Patents Active = 12.5

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 2.1

ph-index = 5

Forward Citations = 153(Granted Patents)

Company Filing History:

8 out of 854

Millennium Pharmaceuticals Limited

patents

2 out of 5,638

The University of Texas System

where one patent can have more than one assignee

Years Active: 2009-2020

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10533227 - Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer (2020-01-14),

2. 10335494 - Combination of aurora kinase inhibitors and anti-CD30 antibodies (2019-07-02),

3. 9926378 - Antibodies that bind OV064 and methods of use therefor (2018-03-27),

4. 9421277 - Antibodies that bind OV064 and methods of use therefor (2016-08-23),

5. 8759490 - Antibodies that bind OV064 and methods of use therefor (2014-06-24),

6. 8323906 - Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer (2012-12-04),

7. 8323645 - Antibodies that bind OV064 and methods of use therefor (2012-12-04),

8. 7494775 - Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer (2009-02-24),

Title: Ole Petter Veiby: Innovator in Cancer Research

Introduction

Ole Petter Veiby is a notable inventor based in Westborough, MA (US), recognized for his significant contributions to cancer research. With a total of 8 patents, he has made strides in developing innovative methods for the identification, assessment, prevention, and therapy of breast and ovarian cancer.

Latest Patents

Veiby's latest patents include groundbreaking inventions such as "Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer." This invention relates to newly discovered nucleic acid molecules and proteins associated with breast or ovarian cancer. It provides compositions, kits, and methods for detecting, characterizing, preventing, and treating human breast or ovarian cancers. Another significant patent is "Combination of aurora kinase inhibitors and anti-CD30 antibodies," which outlines methods for treating cancers. This invention details the combined administration of an Aurora kinase inhibitor and an anti-CD30 antibody, which can be administered simultaneously, separately, sequentially, or consecutively.

Career Highlights

Throughout his career, Veiby has worked with prominent organizations, including Millennium Pharmaceuticals Limited and the University of Texas System. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to advancements in cancer treatment.

Collaborations

Some of his notable coworkers include John Stephen Babcook and Robert C Bast, who have also made significant contributions to cancer research.

Conclusion

Ole Petter Veiby stands out as an influential inventor in the realm of cancer research, with a focus on innovative therapies and methods. His work continues to impact the field significantly, paving the way for future advancements in cancer treatment.

Profile summary based on public USPTO records.